Log In
BCIQ
Print this Print this
 

AC-201 CR

  Manage Alerts
Collapse Summary General Information
Company TWi Pharmaceuticals Holding Inc.
DescriptionControlled-release formulation of a small molecule inhibitor of solute carrier family 22 organic anion urate transporter member 12 (SLC22A12; URAT1), caspase-1 (CASP1) and IL-1 beta
Molecular Target Solute carrier family 22 organic anion urate transporter member 12 (SLC22A12) (URAT1) ; Caspase-1 (CASP1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHyperuricemia / gout
Indication DetailsTreat gout
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today